Researchers conducted the REDEFINE 1 and REDEFINE 2 clinical trials to assess the effect of CagriSema on weight loss in obesity with or without type 2 diabetes.

Researchers conducted a post hoc analysis of the SURMOUNT-1 trial to assess the effect of tirzepatide on kidney function in prediabetes with obesity or overweight.

In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

Discover how celebrities are transforming their bodies with weight-loss drugs like Ozempic and Mounjaro. Explore the science ...